Regulatory obstacles unlikely for Ebos' A$1.17b LifeHealthcare purchase

Regulatory obstacles unlikely for Ebos' A$1.17b LifeHealthcare purchase
Ebos CEO John Cullity doesn't want to pre-empt regulators. (Image: supplied)
Jenny Ruth
Ebos Group's purchase of the LifeHealthcare business is unlikely to have trouble clearing competition watchdogs on either side of the Tasman since its existing medical devices business is quite small.Ebos bought the LMT and National Surgical businesses in late 2019 for A$34 million compared with the LifeHealthcare purchase price of A$1.17 billion.In August last year, it also announced the purchase of Pioneer Medical, a New Zealand-based importer and distributor of spine and major joint implants and associated surgical technologies.Ebos didn...

More Infrastructure

NZX edges lower as Infratil, profit-taking weigh
Finance Market close

NZX edges lower as Infratil, profit-taking weigh

S&P/NZX 50 Index slips with Infratil, Blackpearl and Heartland in focus.

Andy Macdonald 13 Nov 2025
Infratil adds $250m to its billion-dollar asset sale target
Infrastructure

Infratil adds $250m to its billion-dollar asset sale target

Most of the cash will come from sale of mobile tower business Fortysouth.

Fletcher exits Pūhoi toll road investment
Infrastructure

Fletcher exits Pūhoi toll road investment

The $20.2m sale ends Fletcher’s equity role in the Pūhoi to Warkworth toll road.

Staff reporters 10 Nov 2025
EPA’s Allan Freeth sets record straight
Primary Sector

EPA’s Allan Freeth sets record straight

Resignation news a simple case of "bad timing", says environment watchdog CEO.

Pattrick Smellie 07 Nov 2025